Cannabis Business & Export Services
Canada's Leading Cannabis Consultants
We provide all of the cannabis services you require in both the Pre-License and Post License stages of your business—and we can also help to increase profits through exports.
Pre License
- Facility Design
- Cultivation License (Standard, Micro or Nursery)
- Processing License (Standard or Micro)
- Sales for Medical Purposes License
- Research License
- Analytical Testing License
- Retail License
- Laboratory Set Up
- Business Plan
- GPP Report
- Pre License Inspection
- Organizational Security Plan
- Security SOPs
- Evidence package
- Health Canada Further Information Requests
- Revenue Canada License
Post License (Pre-Revenue)
- Export Marketing Strategies
- EU GMP Certification
- GACP SOPs -Export ready
- Business Analysis (Funding options)
- Processing License (Sales Amendment non flower products)
- Equipment Sourcing & Validation
- Funding: Equipment Purchase or Leasing
- Equipment Commissioning
- Labelling and Packaging Compliance
- CBD Products
- Edibles
- HACCP Certification
- Cultivation & Processing License
- Recall Plan
- SOP Review and GAP Analysis(operations)
- Record Keeping Review
- Security Training
- GPP Training
- Exports
- Health Canada Inspection
- Pre-Inspection Audits
- Analytical Testing Specification Preparation
Post License & Exports (Revenue)-
- Export Marketing Strategies
- EU GMP Certification
- GACP SOPs -Export ready
- Safety & Efficacy Evaluation
- Funding Growth & Working Capital
- Health Canada Pre-Inspection Audit
- Post License Gap Analysis
- Amendment Preparation
- Notification Preparation & Filing
- Regulatory Oversight & Due Diligence
- Inspection & Monitoring Reports
- Adverse Event Reporting
- Regulatory Strategy and Oversight
- Labelling and Packaging Compliance
- Exports
- GACP Certification
- SRED Government grants
Psilocybin Dealers License Under CDSA
We provide all of the regulatory services you require in both the Pre-License and Post License stages of your Psilocybin business including exports.
The “Magic mushroom” composition varies depending on genus and species of mushroom. But its principal component is psilocybin, which when converted in the human body to psilocin produce psychoactive effects. Psilocybin and Psilocin fall under Schedule III of the Controlled Drugs and Substances Act (CDSA) and Part J of the FDA. These Regulations control activities such as production, possession and sale of these substances.
Extensive Research is presently being conducted in these substances to treat several conditions, for example:
- Problematic Drug Use
- Obsessive Compulsive Disorder
- Depression
- Anxiety
A Controlled Drugs and Substances Act (CDSA) Dealer’s License permits the following activities depending on what is applied for under the CDSA dealer’s license, such as for example;
- Packaging
- Production
- Transportation
- Distribution to other (CDSA) Dealer’s Licensees & medical patients (Section 56 Exemption)
- Delivery
- Laboratory analysis
- Research and Development (including clinical trials & studies)
- Import/export
Imports and export of these controlled substances are allowed by authorized permit issued by Health Canada after application by a (CDSA) Dealer’s License holder.
We can assist you in obtaining a (CDSA) Dealer’s License at a competitive below industry standard price with personalized service working collaboratively with the Principal of our firm. Price will vary depending on the type of (CDSA) Dealer’s License
Use Growth West's Services, Export Marketing networks & Strategies
Use our comprehensive Cannabis regulatory and export services to increase revenues, profits and cash flows along with our business growth strategies, along with our export marketing resources and networks.